Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K G Parhofer

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Deutsche Medizinische Wochenschrift (1946)|May 3, 2002
[Effect of glucose control on lipid levels in patients with type 2 diabetes]K G Parhofer, E Laubach, H C Geiss, et al.
Journal of Lipid Research|October 3, 2000
Acute effects of low density lipoprotein apheresis on metabolic parameters of apolipoprotein BK G Parhofer, P H Barrett, T Demant, et al.
The Clinical Investigator|November 1, 1993
Effect of pravastatin on metabolic parameters of apolipoprotein B in patients with mixed hyperlipoproteinemiaK G Parhofer, P H Barrett, J Dunn, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|July 31, 1999
Low density lipoprotein apheresis by membrane differential filtration (cascade filtration)H C Geiss, K G Parhofer, M G Donner, et al.
Der Internist|November 21, 2000
[Acute abdominal pain in a 19-year-old patient taking oral contraceptives]K Empen, C Otto, K G Parhofer, et al.
Journal of Public Health (Oxford, England)|November 28, 2019
Impact of perceptions of body size on obesity and weight management behaviour: a large representative population study in an African settingC O Chigbu, U U Aniebue, U Berger, et al.
The Journal of Clinical Investigation|June 1, 1992
Lipoproteins containing the truncated apolipoprotein, Apo B-89, are cleared from human plasma more rapidly than Apo B-100-containing lipoproteins in vivoK G Parhofer, P H Barrett, D M Bier, et al.
Metabolism: Clinical and Experimental|July 27, 1999
Low-density lipoprotein (LDL) oxidizability before and after LDL apheresisM G Donner, K G Parhofer, W O Richter, et al.
Atherosclerosis|April 13, 2005
Effects of ezetimibe on plasma lipoproteins in severely hypercholesterolemic patients treated with regular LDL-apheresis and statinsH C Geiss, C Otto, E Hund-Wissner, et al.
European Journal of Clinical Nutrition|September 17, 2015
Hydrothermally modified slow release corn starch: a potential new therapeutic option for treating hypoglycemia in autoimmune hypoglycemia (Hirata's disease)K Lechner, B Aulinger, S Brand, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Deutsche Medizinische Wochenschrift (1946)|May 3, 2002
[Effect of glucose control on lipid levels in patients with type 2 diabetes]K G Parhofer, E Laubach, H C Geiss, et al.
Journal of Lipid Research|October 3, 2000
Acute effects of low density lipoprotein apheresis on metabolic parameters of apolipoprotein BK G Parhofer, P H Barrett, T Demant, et al.
The Clinical Investigator|November 1, 1993
Effect of pravastatin on metabolic parameters of apolipoprotein B in patients with mixed hyperlipoproteinemiaK G Parhofer, P H Barrett, J Dunn, et al.
Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis|July 31, 1999
Low density lipoprotein apheresis by membrane differential filtration (cascade filtration)H C Geiss, K G Parhofer, M G Donner, et al.
Der Internist|November 21, 2000
[Acute abdominal pain in a 19-year-old patient taking oral contraceptives]K Empen, C Otto, K G Parhofer, et al.
Journal of Public Health (Oxford, England)|November 28, 2019
Impact of perceptions of body size on obesity and weight management behaviour: a large representative population study in an African settingC O Chigbu, U U Aniebue, U Berger, et al.
The Journal of Clinical Investigation|June 1, 1992
Lipoproteins containing the truncated apolipoprotein, Apo B-89, are cleared from human plasma more rapidly than Apo B-100-containing lipoproteins in vivoK G Parhofer, P H Barrett, D M Bier, et al.
Metabolism: Clinical and Experimental|July 27, 1999
Low-density lipoprotein (LDL) oxidizability before and after LDL apheresisM G Donner, K G Parhofer, W O Richter, et al.
Atherosclerosis|April 13, 2005
Effects of ezetimibe on plasma lipoproteins in severely hypercholesterolemic patients treated with regular LDL-apheresis and statinsH C Geiss, C Otto, E Hund-Wissner, et al.
European Journal of Clinical Nutrition|September 17, 2015
Hydrothermally modified slow release corn starch: a potential new therapeutic option for treating hypoglycemia in autoimmune hypoglycemia (Hirata's disease)K Lechner, B Aulinger, S Brand, et al.
Pageof 10